SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-619453
Filing Date
2016-06-13
Accepted
2016-06-13 06:08:38
Documents
2
Group Members
CRAIG R. STAPLETON

Document Format Files

Seq Description Document Type Size
1 SC 13G d209612dsc13g.htm SC 13G 44032
2 EX-99.1 d209612dex991.htm EX-99.1 3486
  Complete submission text file 0001193125-16-619453.txt   49045
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89517 | Film No.: 161709831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 OLD FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830
Business Address 55 OLD FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830 (203) 622-1382
Stapleton Pharma LLC (Filed by) CIK: 0001676901 (see all company filings)

IRS No.: 270867566 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SC 13G